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ABSTRACT
Introduction: Maternal mortality is a potentially
preventable public health issue. Maternal morbidity is
increasingly of interest to aid the reduction of maternal
mortality. Obstetric patients admitted to the intensive
care unit (ICU) are an important part of the global
burden of maternal morbidity. Social determinants
influence health outcomes of pregnant women.
Additionally, intimate partner violence has a great
negative impact on women’s health and pregnancy
outcome. However, little is known about the contextual
and social aspects of obstetric patients treated in the
ICU. This study aimed to conduct a systematic review
of the social determinants and exposure to intimate
partner violence of obstetric patients admitted to an
ICU.
Methods and analysis: A systematic search will be
conducted in MEDLINE, CINAHL, ProQuest, LILACS
and SciELO from 2000 to 2016. Studies published
in English and Spanish will be identified in relation
to data reporting on social determinants of health
and/or exposure to intimate partner violence of
obstetric women, treated in the ICU during
pregnancy, childbirth or within 42 days of the end of
pregnancy. Two reviewers will independently screen
for study eligibility and data extraction. Risk of bias
and assessment of the quality of the included
studies will be performed by using the Critical
Appraisal Skills Programme (CASP) checklist. Data
will be analysed and summarised using a narrative
description of the available evidence across studies.
This systematic review protocol will be reported
according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses Protocols
(PRISMA-P) guidelines.
Ethics and dissemination: Since this systematic
review will be based on published studies, ethical
approval is not required. Findings will be presented
at La Trobe University, in Conferences and
Congresses, and published in a peer-reviewed
journal.
Trial registration number: CRD42016037492.
INTRODUCTION
Maternal mortality is a tragic event which has a
dramatic negative impact on the remaining
family members and motherless children. The
Sustainable Development Goal 3.1 targets a
challenging global commitment for the reduc-
tion of maternal mortality ratio (MMR) to <70
per 100 000 live births by 2030.1 However, 830
maternal deaths occur daily across the world
representing a global MMR of 216 per 100 000
live births.2 Maternal mortality is only a small
proportion of the global burden of maternal
morbidity and has been compared with the tip
of the enormous iceberg where the immense
base is formed by maternal morbidity cases3–5
including patients affected by severe acute
maternal morbidity along with their long-term
related complications and disabilities.6–10
Strengths and limitations of this study
▪ The comprehensive search strategy of this review
will identify a wide range of studies from diverse
geographic areas, and include studies published
in English and Spanish.
▪ Measures and reporting of social determinants
and exposure to intimate partner violence of criti-
cally ill obstetric women affected by severe acute
maternal morbidity treated in the intensive care
unit (ICU) may be absent in the literature.
▪ It is likely that there will be some variability
(related to clinical and/or methodological diver-
sity) in the studies due to the absence of stan-
dardised criteria and/or definition for reporting
data on severe acute maternal morbidity in the
ICU, making it difficult to compare outcomes
across different settings and studies.
▪ Additionally, it is expected that most included
studies might be predominantly observational
studies.
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Severe acute maternal morbidity is also known as near
miss and both terms are often used interchangeably
across studies.11 The WHO has developed a tool com-
prising clinical, management and laboratory-based cri-
teria taking into account organ system dysfunction
parameters for defining severe maternal complica-
tions.11 12 However, some investigators consider that the
application of these criteria may require the use of
advanced laboratory measurements, extensive clinical
monitoring and availability of well-trained human
resources which could be difficult to perform in low-
income countries,13 and even in high-income coun-
tries.14 Thus, there is a lack of internationally accepted
criteria for defining severe acute maternal morbidity
worldwide and its definition varies across studies.15–23
Regardless, the review of severe acute maternal mor-
bidity has emerged as a potential tool to improve the
quality of maternity care.11 20 24–26 It can be used as a
complement to maternal deaths review to allow a more
comprehensive assessment for improving maternal
health and preventing life-threatening obstetric condi-
tions and fatal maternal events.4 19 27 28 Pregnancy,
childbirth and the postpartum period can be affected by
severe acute maternal morbidity; some women encoun-
ter devastating conditions which require specialised cri-
tical care in the intensive care unit (ICU). The
management of obstetric patients in the ICU involves
unique challenges due to the physiological changes of
pregnancy, the diverse pregnancy-related disorders and
the need to care for two lives.29–32 Studies have shown
that the incidence of ICU admission varies from 0.04%
to 4.54%22 33 34 and the main common causes for ICU
admission were hypertensive disorders (0.09% of delive-
ries), obstetric haemorrhage (0.07%) and sepsis
(0.02%).33
Many scholars have argued that ICU admission can be
considered as an alternative marker for severe maternal
morbidity20 35–37 including severe acute maternal mor-
bidity.21 22 38 In agreement with this, the use of ICU
admission was previously proven to have high sensitivity
(86.4%), specificity (87.8%) and positive predictive
value (0.85) for identifying severe maternal morbid-
ity.20 37 39–41 This may fail to identify some severe
pregnancy-related cases because ICU admission depends
on diverse factors including patient’s condition, guide-
lines or criteria established by the healthcare facility,
resources available within a hospital such as number of
beds or healthcare professionals working in the ICU,
among others, which may vary across and within settings
and countries.11 35 36 42 However, the study of this par-
ticular population of obstetric patients provides valuable
information since obstetric patients treated in the ICU
represent the most critically ill patients and have shown
to be an important component of the maternal morbid-
ity spectrum requiring timely managed care.22 43
Additionally, the profile of ICU admission has been
shown to be similar worldwide, albeit with a higher
maternal mortality rate in the ICUs of developing
countries.33 Thus, it also seems appropriate to use ICU
admission to study maternal characteristics and asso-
ciated factors of obstetric patients with severe maternal
morbidity in the ICU.43
This wide gap in health outcomes reflects disparities
between developed and developing countries resulting
from a combination of factors related to social determi-
nants. These include difficulties in accessing healthcare
services, gender inequalities, type of healthcare system,
poverty level, educational attainment, economic, social
and behavioural factors, among others.44–48 Social deter-
minants shape the exposure and vulnerability of popula-
tions49 playing an important role in the health of
women and their newborns.50 Studies on maternal mor-
bidity should not be limited to looking at medical
causes; it is also important to consider the contribution
of social determinants and other factors influencing
health outcomes at the individual, societal and health
system level and their effect on the continuum of care
for improving maternal health.5 47 48 51 52
Additionally, violence against women is one of the major
public health issues and a violation of human rights53 54
and many women endure in silence this abuse which is
usually exerted by their intimate partners. Globally, 30% of
women have experienced intimate partner violence (IPV)
during their lifetime.53 55 56 However, the prevalence of
IPV has a wide range across studies. Garcia-Moreno et al57
reported that the lifetime prevalence of physical or sexual
IPV or both was from 15% to 71%; and Fulu et al58 found
in a study where 10 178 men were interviewed that the
prevalence of physical or sexual violence, or both, was
between 25.4% and 80.0%, and this prevalence was higher
after including emotional or economic abuse (39.3–
87.3%). Furthermore, the rate of IPV during pregnancy
was from 1.2% to 38%.59 Previous systematic reviews on
violence in pregnancy have reported that the prevalence
of IPV against pregnant women ranged from 0.9% to
20.1% in developed countries,60 2% to 57% in African
countries61 and 3% to 44% in Latin America and
Caribbean countries.62
In addition, there has been increased concern regard-
ing the negative contribution of violence against women
to maternal deaths,63–66 and many studies have reported
negative and fatal repercussions of IPV on women’s
health67 68 including during pregnancy and the puerper-
ium period where women could be more vulnerable to
partner abuse.62 64 67 69 70 However, little is known about
the underlying factors that undermine maternal health
and most studies have no focus particularly on contex-
tual and social aspects including the influence of social
determinants and the impact of IPV on critically ill
obstetric patients affected by severe maternal morbidity
in the ICU.
HYPOTHESIS
Some social determinants and/or the exposure to IPV
influence ICU admission of obstetric patients.
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REVIEW QUESTIONS
▸ What are the social determinants described among
obstetric patients admitted to an ICU?
▸ Has exposure to IPV of obstetric patients admitted to
an ICU been reported?
▸ What other characteristics and outcomes are reported
among obstetric patients admitted to an ICU?
OBJECTIVES
▸ To review available evidence pertaining to social
determinants as well as exposure to IPV of obstetric
patients admitted to an ICU.
▸ To review other characteristics and outcomes of
obstetric patients admitted to an ICU.
METHODS
This systematic review protocol will be developed and
reported according to the guidelines of Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
Protocols (PRISMA-P),71 72 which include the use of the
PRISMA-P checklist (see online supplementary appendix
1), and will follow the methodology published previ-
ously.33 The final review will be also reported considering
the recommended items to be addressed in a systematic
review in accordance with the PRISMA statement.73
Study registration
This review protocol is registered in the PROSPERO
International Prospective Register of Systematic Reviews
with registration number CRD42016037492 (http://www.
crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD
42016037492).
Types of studies
Any studies with relevant data related to social determi-
nants and/or exposure to IPV of obstetric patients admitted
to an ICU. These could be experimental and observational
studies including randomised controlled trials, non-
randomised controlled trials, quasi-experimental, longi-
tudinal studies, cohort studies, case–control studies and
cross-sectional studies.
Types of participants and settings
Women who were treated in the ICU during pregnancy,
childbirth and within 42 days of the end of pregnancy
including postpartum, abortion and ectopic pregnancy.
This review will consider any healthcare facility which
has an ICU, and independent private or public ICUs.
Intervention(s), exposure(s)
Any social determinants (including age, level of educa-
tion, marital status, income, place of residence, occupa-
tion, socioeconomic status, partner’s education, booking
status, ethnicity (race), immigration status or country of
origin, body mass index, behavioural factors, type of
health insurance and others if described) and/or IPV in
this study population.
Comparator
For any identified case–control study, the comparator
will be women who were not treated in the ICU during
pregnancy, childbirth and within 42 days of the end of
pregnancy.
Types of outcome measures
Primary outcomes
The following will be assessed if described in the eligible
studies:
▸ Rate of social determinants identified among obstet-
ric patients admitted to an ICU.
▸ Rates and types of IPV of obstetric patients admitted
to an ICU.
Other outcomes (secondary outcomes)
The following will be considered if described in the
eligible studies:
▸ Rate of ICU admission (or rate of severe maternal
morbidity which includes obstetric death cases).
▸ Rate of severe acute maternal morbidity (which did
not include obstetric death cases) in the ICU.
▸ Main clinical cause(s) and/or diagnoses for admis-
sion to an ICU.
▸ ICU characteristics including severity of illness, dur-
ation of ICU stay and others if indicated (ICU
technologies).
▸ Main obstetric characteristics and/or pre-existing
medical conditions of obstetric patients admitted to
an ICU.
▸ Numbers of maternal deaths in the ICU.
▸ Rate of maternal mortality (case fatality rate, CFR) in
the ICU.
▸ Principal causes of maternal deaths in the ICU.
▸ Pregnancy and perinatal outcomes.
Search strategy
A comprehensive systematic literature search will be
undertaken between 1 January 2000 and 31 December
2016 in MEDLINE, ProQuest, CINAHL, Latin American
and Caribbean Health Science Information Database
(LILACS) and SciELO (Scientific Electronic Library
Online).
The associations between social inequalities and vul-
nerabilities, domestic violence and maternal death were
first analysed and described in the 1997–1999 UK
Confidential Enquiry into Maternal Death, published in
December of 2001.74 The association of domestic vio-
lence and maternal death was recognised by a dedicated
chapter for the first time in the 2000–2002 UK
Confidential Enquiry into Maternal Death, published in
November of 2004.75 Earlier and systematic reviews on
severe maternal morbidity and ICU admission22 31 33 35 76
reported few or no details related to social determinants,
and no data on IPV in the maternal ICU admissions.
Consequently, this systematic review is targeting the years
2000–2016 to examine if there has been any reporting
of social inequalities and vulnerabilities, and IPV in
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studies on maternal admission to an ICU. This time
frame is considered appropriate as it parallels the recog-
nition of, and interest in, the association of health deter-
minants and violence against women with maternal
mortality, and acknowledges the lack of data reported on
these issues in literature reviews covering maternal mor-
bidity studies earlier than 2000.
We will use the following subject heading and/or free-
text words: ICU, intensive care, critical care and critically
ill in combination with the next MeSH terms and/or
free-text words: social determinants of health, determi-
nants, social, social class, socioeconomic, demographic,
characteristics, demographic characteristics, violence,
violence against women, gender-based violence, family
violence, domestic violence, exposure to violence, bat-
tered women, IPV, partner abuse, spouse abuse, spousal
abuse, pregnancy, pregnancy complications, pregnancy
morbidity, obstetrics, mother, maternity, maternal mor-
tality, maternal death, severe maternal morbidity, severe
acute maternal morbidity, near miss, severe obstetric
morbidity, partum, childbirth, postpartum, postpartum
morbidity, puerperium, parturient and postnatal
morbidity.
The general search strategy is shown in online
supplementary appendix 2, and will be adapted and
modified appropriately according to each database. In
addition, hand searching will be also conducted by
screening the reference list of eligible articles for
further identification of other additional relevant
studies. Studies published in English and Spanish will be
considered in this review. The first author will conduct
the electronic searches and initial identification of
studies in MEDLINE, ProQuest, CINAHL, LILACS and
SciELO.
It is important to note that there are diverse chal-
lenges and barriers during the conduct of a systematic
review related to maternal mortality and morbidity.77
This is because studies have shown a wide range of cri-
teria to define severe maternal morbidity, severe acute
maternal morbidity and maternal admission to an
ICU.33 34
Data collection and analysis
Eligibility criteria of the studies
The inclusion criteria will be:
1. Experimental and observational studies (such as
cohort studies, case–control studies, cross-sectional
studies).
2. Women admitted to an ICU as stated by the authors
in their published research during pregnancy, child-
birth or within 42 days of termination of pregnancy
(including postpartum, abortion or ectopic
pregnancy).
3. The whole (total) population of patients treated in
an ICU during pregnancy, childbirth or within
42 days of termination of pregnancy (including post-
partum, abortion or ectopic pregnancy).
4. Studies written in English and Spanish between the
period 2000 and 2016, which consider as a setting
any healthcare facilities with an ICU or independent
private or public ICUs.
5. Studies with relevant data related to social determi-
nants and/or IPV.
The exclusion criteria will be:
1. Any qualitative investigations, study protocols, theses,
case reports, letters, opinions, editorials, weekly
reports, congress abstracts or reviews.
2. Studies which evaluated specific condition(s) or
disease(s) treated in the ICU during pregnancy,
childbirth or within 42 days of the end of pregnancy
(including postpartum, abortion or ectopic preg-
nancy), for example, restricted to just eclampsia or
sepsis.
3. Subgroup of participants treated in the ICU during
pregnancy, childbirth or within 42 days of the end of
pregnancy (including postpartum, abortion or ectopic
pregnancy), for example, anaesthetic complications.
4. Duplicate studies that have used the same study
population or data (the most recent or relevant pub-
lication will be used for studies published in more
than one journal).
5. Studies with absence of data in relation to social
determinants and/or IPV.
Data management of the studies
The bibliographic software program Endnote (V.X7) will
be used to manage and store relevant studies. Duplicate
references will be found and removed by using this soft-
ware program. A checklist will be developed based on the
eligibility criteria of this review. Online supplementary
appendix 3 shows the flow diagram through the main
phases of a systematic review.73
Data selection of the studies
The screening of potential studies will be assessed inde-
pendently by two investigators. They will screen titles
and abstracts and/or full texts of all non-duplicate
studies resulting from the electronic search, and assess
eligibility of potential studies. It might be necessary to
obtain and read the full text of the studies from this
initial stage of the review—before deciding their exclu-
sion—because of the expected variability of reporting
and defining severe acute maternal morbidity and ICU
admission in the studies. In addition, some studies may
not describe adequately in the abstracts sufficient detail
to ensure that the selection criteria were met. The first
author will obtain full texts of potential eligible studies.
If there are any doubts about whether or not the study
(ies) should be included at this stage, this (these) study
(ies) will be temporarily included for more evaluation,
and proceed to the next stage.
The full version of all selected retained studies will be
examined again for further evaluation, taking into
account the selection criteria of the studies, by four
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investigators (two for studies written in English, and two
for studies written in Spanish).
The final list of selected articles will be reviewed
independently. Reasons for exclusion will be documen-
ted for each excluded study. Results will be compared.
Disagreements will be resolved by discussion and con-
sensus between the two authors. If needed, consultation
of a third author will be performed when consensus is
not reached. It is expected that the disagreement rate
between the two reviewers will not be more than 10%.77
Appraisal assessment of methodological quality
of the included studies
It is anticipated that most of the eligible studies will be
non-randomised, and there is a wide range of tools for
assessing quality and bias of observational studies.78
However, evaluating the risk of bias and methodological
quality of observational studies might be problematic, and
there is no consensus particularly for evaluating risk of
bias.79 According to Grading of Recommendations,
Assessment, Development and Evaluation (GRADE)
guidelines, observational studies begin as low-quality evi-
dence which can be rated up.80 81 Additionally, the work of
the Equator (Enhancing the Quality and Transparency Of
health Research) Network (http://www.equator-network.
org/about-us/) facilitates transparent and accurate report-
ing by providing guidelines and tools to allow achieving
high standard, reproducibility and usefulness of health
studies including study protocols.
For this review, the risk of bias and quality of each
included study will be assessed using the Critical
Appraisal Skills Programme (CASP) checklist.82 This
process will be performed independently by four
authors (two for studies published in English, and two
for studies published in Spanish) and disagreement will
be resolved by discussion and consultation of a third
author when necessary. Studies will be categorised as
very low (unclear), low, moderate or high quality of
data.
Data extraction
Two investigators will independently extract all data
items (see online supplementary appendix 4) of each
included study by using a standardised data extraction
form in accordance with the recommendations of the
Cochrane Collaboration and as previously described.33
We will ensure that there are no data errors. A third
author will randomly cross-check these data. Any dis-
agreements will be resolved by consensus between the
two authors, and a third author will act as arbitrator if
consensus is not reached.
Data items
The following descriptive items (see online
supplementary appendix 4) will be extracted: (1)
general characteristics of the studies, (2) social determi-
nants, (3) IPV characteristics, (4) ICU characteristics,
(5) obstetric characteristics, (6) pre-existing medical
conditions (comorbidities) and (7) pregnancy and peri-
natal outcomes.
In summary, we will extract information related to
social determinants of health comprising age, marital
status, place of residence, socioeconomic status (by
using level of education and/or occupation and/or
income), partner’s education, booking status, ethnicity
(race), immigration status or country of origin, body
mass index, behavioural factors (smoking, alcohol con-
sumption and use of illicit drugs) and type of health
insurance, and others if reported; and exposure to IPV
including rates and types of IPV among obstetric patients
admitted to an ICU.
Additional information concerning the general
characteristics of each study will be extracted: author’s
name, journal, year of publication, type of design, tem-
porality, setting, country, period and number of partici-
pants. Besides, studies will be also examined in relation
to ICU characteristics including rate of ICU admission
(severe maternal morbidity), rate of severe acute mater-
nal morbidity, main clinical cause(s) and/or diagnoses
for ICU admission, length of stay in the ICU, severity of
illness, and others if described (ICU technologies);
numbers of maternal deaths, maternal mortality rate
(CFR) and principal causes of maternal deaths; main
obstetric characteristics and pre-existing medical condi-
tions (comorbidities) of the participants; and pregnancy
and perinatal outcomes.
The main clinical conditions of severe (acute) mater-
nal morbidity, which were the cause(s) for ICU admis-
sion, will include categories previously described:33 (1)
hypertensive disorders of pregnancy involving (severe)
pre-eclampsia, eclampsia and HELLP syndrome; (2)
obstetric haemorrhage including antepartum, intrapar-
tum and postpartum causes as reported by individual
studies; (3) sepsis/infections; (4) abortions; (5) other
direct obstetric complications (included thrombolysis,
thromboembolism, pulmonary embolism, pulmonary
oedema, acute fatty liver of pregnancy, amniotic fluid
embolism, abnormal adherence of placenta, intrauterine
fetal death, gestational diabetes and peripartum cardio-
myopathy); (6) non-direct obstetric complications which
were all other cases not identified as one of the above
(including medical conditions and those cases cate-
gorised as organ or system failure); and (7) anaesthetic
complications.
Data synthesis and analysis
Data will be synthesised and analysed to answer the
research questions. Data will be summarised by country
of origin and according to the World Bank’s classifica-
tion of countries by income which consists of four cat-
egories: low income, lower middle income, upper
middle income and high income. This is based on the
gross national income (GNI), per capita of the countries
in 2014. Then, low-income countries are those with a
GNI per capita ≤$1045 in 2014; middle-income coun-
tries >$1045 and <$12 736; high-income countries
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≥$12,736. Lower middle-income and upper middle-
income countries are divided at a GNI per capita of
$4125.83
Continuous and categorical variables will be sum-
marised according to the presentation of data in each
study. It is anticipated that there will be a large variability
(related to clinical and methodological diversity84) of
reporting social determinants or exposure to IPV across
studies. Then a narrative description of the available evi-
dence will be conducted considering which determi-
nants are significant and their association with the
outcome based on data availability of the studies. It will
be also indicated if those findings were adjusted for con-
founders. In a similar manner, data on IPV will be sum-
marised indicating whether or not it was reported, as
well as the rate and types of IPV of the eligible studies.
Additional data analysis will be made if possible in order
to assess the comparisons between studies.33
The rate of ICU admission will be mainly shown as
the number of obstetric patients per 1000 live births.
However, it could be reported as per 1000 deliveries or
1000 maternities or using other denominators according
to data shown in each study. These differences are due
to the diversity of data reporting ICU admission and
lack of consensus in this research area. For those studies
which did not report the rate of ICU admission, this
value will be calculated if it is possible by using informa-
tion from the study regarding the number of partici-
pants in the ICU per total live births or deliveries or
maternities or using other denominators as indicated by
the authors.
The rate of the main clinical condition causing ICU
admission will be described and/or calculated (if pos-
sible) as the number of participants with the specific
clinical cause per 1000 deliveries/live births/maternities
or using other denominators according to the study.
Other ICU characteristics comprising length of stay in
the ICU, severity of illness and others if described, as
well as principal causes of maternal deaths, numbers of
maternal deaths, maternal mortality (case fatality) rate,
main obstetric characteristics and pre-existing medical
conditions of the participants, pregnancy and perinatal
outcomes, will be included by using a narrative
summary. Maternal mortality (case fatality) rate will be
presented and/or calculated (if possible) as a percent-
age resulting of the number of maternal deaths per a
total number of obstetric patients in the ICU.
This review will present the results as reported in the
original studies. However, as indicated previously, we will
calculate data, where possible, using the original infor-
mation from the study such as for rate of ICU admission,
rate of main clinical condition causing ICU admission
and maternal mortality (case fatality) rate. In addition,
data from figures will be used if information is reported
either in the text or in the table.
For duplicate studies that have used the same study
population or data, the most recent or relevant publica-
tion will be used for those studies published in more
than one journal, and data might be linked together if
needed.
In summary, data analysis will be performed according
to data shown in the eligible studies, and statistical
expertise will be consulted as needed. The Statistical
Package for the Social Sciences (SPSS) V.24 will be used
for all the analyses.
Subgroup analyses
It is planned that subgroup analyses will be performed
by considering the World Bank’s classification of coun-
tries by income (when data are sufficient). In addition,
if there is a sufficient number of studies with a design
other than cross-sectional, another subgroup analysis will
be performed by considering the study design.
Sensitivity analysis
It is expected that a majority of, or all, studies will be
observational (non-randomised) studies. Then a sensitiv-
ity analysis will be conducted considering the quality of
studies. It will be determined if studies at high risk of
bias or only moderate-quality to high-quality studies
could change the result of this review if they are
included in the study in comparison with when they are
not included. Further sensitivity analyses will be consid-
ered if necessary.
PRESENTING AND REPORTING THE RESULTS
The selection process of the studies in the final review
will be summarised using a flow diagram according to
guidelines of the PRISMA statement (see online
supplementary appendix 3) through the main phases of
the systematic review consisting of identification, screen-
ing, assessment of eligibility and selection of the
studies.73 Quantitative data of all information for the
present systematic review will be shown in tables depend-
ing on data shown in the studies by principally indicat-
ing the author’s name, country and considering the
World Bank’s classification of countries by income or by
study design (when data are sufficient), and accompan-
ied by narrative summaries. The appraisal assessment of
quality for each eligible study will be presented in a
table as another online supplementary appendix.
POTENTIAL AMENDMENTS
Amendments to this protocol are not expected.
However, if any are required, these amendments will be
reported transparently.
CONCLUSION AND IMPLICATIONS
Severe maternal morbidity is one of the major public
health problems which require effective actions to
reduce life-threatening obstetric complications leading
to ICU admission and maternal deaths. This problem is
particularly broad in developing countries where there is
a higher MMR since these countries account for 99% of
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maternal deaths worldwide. However, maternal mortality
is potentially preventable; as a consequence, it is import-
ant to understand factors influencing severe maternal
morbidity, particularly paying attention to social determi-
nants and exposure to IPV of this population of obstetric
patients. Social determinants affect outcomes of preg-
nant women, and IPV has a great negative impact on
women’s health and during all stages of pregnancy,
including an association with maternal mortality. This
study will extend knowledge by conducting a systematic
review to identify research gaps on severe maternal mor-
bidity, especially in regard to health determinants and
IPV.
It is important to note that the findings of this review
will be prudently explained and the conclusion will be
interpreted cautiously, considering the potential limita-
tions of this study. This is because most included studies
will be mainly observational (cross-sectional) studies,
which makes it difficult to determine risk factors.
Another limitation will be related to the diversity of clini-
cal and methodological approaches used in the included
studies and the absence of standardised criteria and/or
definition for reporting data related to severe maternal
morbidity in the ICU. It might be also possible to lose
relevant data since this review includes only studies pub-
lished in English and Spanish.
Notwithstanding these limitations, this study will
provide valuable information and contribute to a better
understanding of the global burden of maternal morbid-
ity, and may provide direction and the basis for further
studies in obstetric women treated in the ICU particu-
larly affected by severe maternal morbidity.
ETHICS AND DISSEMINATION
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This study will be based on previous published studies
and does not involve collection of new or identifiable
data. Accordingly, no ethical review is required.
Publication plan
It is planned that the findings of this review will be pre-
sented at La Trobe University, conferences and con-
gresses and form part of the first author’s PhD thesis.
The research will be published in a peer-reviewed
journal. It is also planned to update this review in future
to monitor any changes which may contribute to
develop further studies and/or guide health policies.
Registration
This study has been registered in the International
Prospective Register of Systematic Reviews (PROSPERO)
with registration number CRD42016037492 (http://www.
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